Reference
Medicines and Healthcare products Regulatory Agency (UK). Fingolimod (Gilenya): updated advice about the risks of serious liver injury and herpes meningoencephalitis. Internet Document : 7 Jan 2021. Available from: URL: https://www.gov.uk/drug-safety-update/fingolimod-gilenyav-updated-advice-about-the-risks-of-serious-liver-injury-and-herpes-meningoencephalitis
Rights and permissions
About this article
Cite this article
Risks of serious liver injury, herpes meningoencephalitis with Gilenya. Reactions Weekly 1839, 9 (2021). https://doi.org/10.1007/s40278-021-89847-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-89847-8